BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7887832)

  • 1. Biocompatibility of a heparin-bonded membrane oxygenator (Carmeda MAXIMA) during the first 90 minutes of cardiopulmonary bypass: clinical comparison with the conventional system.
    Shigemitsu O; Hadama T; Takasaki H; Mori Y; Kimura T; Miyamoto S; Sako H; Soeda T; Kawawaki Y; Uchida Y
    Artif Organs; 1994 Dec; 18(12):936-41. PubMed ID: 7887832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
    Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
    Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
    Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a silicone coated hollow fiber oxygenator.
    Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
    ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
    van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generation.
    Tamiya T; Maeo Y; Okada T; Ogoshi S; Fujimoto S; Yasui H
    J Thorac Cardiovasc Surg; 1992 Jan; 103(1):78-86. PubMed ID: 1728718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit.
    Bochenek A; Religa Z; Kustosz R; Wnuk-Wojnar AM; Wnuk R; Wojnar J; Woś S; Wites M; Zembala M; Spyt T
    Nephrol Dial Transplant; 1991; 6 Suppl 3():75-80. PubMed ID: 1775272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood--artificial surface interactions during cardiopulmonary bypass. A comparative study of four oxygenators.
    Benedetti M; De Caterina R; Bionda A; Gardinali M; Cicardi M; Maffei S; Gazzetti P; Pistolesi P; Vernazza F; Michelassi C
    Int J Artif Organs; 1990 Aug; 13(8):488-97. PubMed ID: 2146229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Carmeda BioActive Surface coating versus Trillium Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass.
    Palanzo DA; Zarro DL; Manley NJ; Montesano RM; Quinn M; Elmore BA; Gustafson PA; Castagna JM
    Perfusion; 2001 Jul; 16(4):279-83. PubMed ID: 11486846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
    Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
    Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation.
    Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP
    J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation and aggregation during normothermic cardiopulmonary bypass.
    Misawa Y; Konishi H; Kawahito K; Fuse K
    Jpn J Thorac Cardiovasc Surg; 2001 Jan; 49(1):21-8. PubMed ID: 11233238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental use of a compact centrifugal pump and membrane oxygenator as a cardiopulmonary support system.
    Suenaga E; Naito K; Cao ZL; Suda H; Ueno T; Natsuaki M; Itoh T
    Artif Organs; 2000 Nov; 24(11):912-5. PubMed ID: 11119082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass.
    Ereth MH; Nuttall GA; Clarke SH; Dearani JA; Fiechtner BK; Rishavy CR; Buda DA; Shaw TA; Orszulak TA; Oliver WC
    J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):545-50; discussion 539-41. PubMed ID: 11687991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.